Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Dec 5, 2006

Oxford Gene Technology Tapped to Provide Microarrays for HIV Vaccine Research

  • Oxford Gene Technology (OGT) will design and fabricate microarrays for the Innate Discovery Team as part of the Centre for HIV-AIDS Vaccine Immunology (CHAVI) project.

    OGT will design and develop an optimized oligonucleotide microarray to study genes of interest involved in the cellular immune response in early-stage HIV infected patients. The microarrays will be printed using the OGT ink jet in-situ synthesis platform. It will also investigate the use of its Multi Sample Array format enabling the parallel analysis of multiple samples. This will effectively reduce the cost per sample and speed up sample processing time.



Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »